<DOC>
	<DOCNO>NCT01817023</DOCNO>
	<brief_summary>The purpose study verify simultaneous integrate boost IMRT ( SIB-IMRT ) alone non-inferior SIB-IMRT combine concurrent chemotherapy low-risk locally advanced nasopharyngeal carcinoma .</brief_summary>
	<brief_title>The Role Concurrent Chemotherapy Lower Risk Locally Advanced Nasopharyngeal Carcinoma ( NPC ) Era IMRT</brief_title>
	<detailed_description>- There several randomize clinical trial confirm concurrent chemoradiotherapy ( CCRT ) superior radiotherapy ( RT ) alone locally advanced NPC , patient trial treat conventional radiotherapy technique . - As new technique IMRT use clinical practice , role concurrent chemoradiotherapy ( CCRT ) seem blur , two Hongkong phaseIII study ( NPC9901/9902 ) , half patient treat 3-dimensional conformal radiotherapy ( 3DCRT ) /IMRT , result show significant different term overall survival RT alone CCRT group . Furthermore , several large sample size retrospective study China , show advantage CCRT RT alone treat SIB-IMRT . - In analysis benefit CCRT , ( Lin , et.al , IJROBP,2004 ; 60:156-164 ) , author divide locally advanced NPC patient two group , high-risk group define patient meet least one follow criterion : nodal size &gt; 6 cm , ( 2 ) supraclavicular node metastasesN3 , T4N2 multiple neck node metastases 1 node &gt; 4cm . - Based information , hypothesize , low-risk locally advanced NPC patient , may need CCRT SIB-IMRT treatment .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histopathological proven nonkeratin nasopharyngeal carcinoma AJCC 7th edition stage III/IVM0 , without one follow factor : node size &gt; 6cm ; supraclavicular metastasis node ; T4N2 ; multiple neck node metastases 1 node &gt; 4 cm Life expectancy≥6 month Adequate renal function , define follow : Serum creatinine &lt; 2 x institutional upper limit normal ( ULN ) within 2 week prior registration creatinine clearance rate ( CCr ) ≥ 50 ml/min within 2 week prior registration determine 24 hour collection estimate CockcroftGault formula : CCr male = [ ( 140 age ) x ( wt kg ) ] [ ( Serum Cr mg/dl ) x ( 72 ) ] CCr female = 0.85 x ( CCrmale ) The following assessment require within 2 week prior start registration : Na , K , Cl , glucose , Ca , Mg , albumin Prior invasive malignancy ( except nonmelanomatous skin cancer ) unless disease free minimum 3 year ; noninvasive cancer ( For example , carcinoma situ breast , oral cavity , cervix permissible ) permit even diagnose treat &lt; 3 year ago Prior radiotherapy region study cancer would result overlap radiation therapy field Severe , active comorbidity Treatment planning meet requirement prescription dose .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Nasopharyngeal carcinoma</keyword>
	<keyword>current chemotherapy</keyword>
	<keyword>intensity-modulated radiotherapy</keyword>
	<keyword>low-risk</keyword>
</DOC>